Type 2 diabetes mellitus (T2DM) is one of the most common metabolic disorders worldwide. Initial treatment begins with oral medications however, many patients will eventually require exogenous insulin. Around 50% of patients with diabetes complications had a delay in treatment with insulin. Therefore, it is imperative that healthcare practitioners know how to address the barriers in treatment delay in T2DM patients requiring insulin. This e-learning module identifies the barriers and causes of treatment delay in insulin treatment and summarizes the principles on how to start insulin in T2DM patients.
Upon completion of the educational activity, participants should be able to
Dr Prof Hemraj Chandalia
Director, Endocrinology, Diabetes and Metabolism
Jaslok Hospital, Mumbai
Keywords: diabetes mellitus, insulin